Document is current
Any future updates will be listed below
-
Authors
Tanoli, Ziaurrehman https://orcid.org/0000-0003-2435-9862
Fernández-Torras, Adrià
Özcan, Umut Onur https://orcid.org/0000-0002-7317-1682
Kushnir, Aleksandr
Nader, Kristen Michelle https://orcid.org/0009-0002-1068-0831
Gadiya, Yojana https://orcid.org/0000-0002-7683-0452
Fiorenza, Laura
Ianevski, Aleksandr https://orcid.org/0000-0002-7780-482X
Vähä-Koskela, Markus https://orcid.org/0000-0001-7764-7820
Miihkinen, Mitro https://orcid.org/0000-0001-6822-3647
Seemab, Umair
Leinonen, Henri https://orcid.org/0000-0002-0388-832X
Seashore-Ludlow, Brinton
Tampere, Marianna
Kalman, Adelinn
Ballante, Flavio https://orcid.org/0000-0002-4831-3423
Benfenati, Emilio
Saunders, Gary
Potdar, Swapnil
Gómez García, Ismael
García-Serna, Ricard
Talarico, Carmine
Beccari, Andrea Rosario https://orcid.org/0000-0001-6830-2695
Schaal, Wesley
Polo, Andrea
Costantini, Susan
Cabri, Enrico
Jacobs, Marc https://orcid.org/0000-0003-4153-3930
Saarela, Jani
Budillon, Alfredo https://orcid.org/0000-0002-6330-6053
Spjuth, Ola https://orcid.org/0000-0002-8083-2864
Östling, Päivi
Xhaard, Henri
Quintana, Jordi
Mestres, Jordi https://orcid.org/0000-0002-5202-4501
Gribbon, Philip
Ussi, Anton E.
Lo, Donald C.
de Kort, Martin https://orcid.org/0000-0002-7264-5436
Wennerberg, Krister https://orcid.org/0000-0002-1352-4220
Fratelli, Maddalena https://orcid.org/0000-0002-1769-3427
Carreras-Puigvert, Jordi
Aittokallio, Tero https://orcid.org/0000-0002-0886-9769
- License Information
-
More Information
Article History
Accepted: 19 February 2025
First Online: 18 March 2025
Competing interests
: A.F.-T., I.G.G., R.G.-S., J.Q. and J.M. are employees of Chemotargets, a partner of the REMEDi4ALL project. ClarityVista is a software platform developed by Chemotargets. J.C.-P. and O.S. declare ownership in Phenaros Pharmaceuticals AB. T.C. and A.R.B. are employees of Dompé farmaceutici SpA, a partner of the REMEDi4ALL project. All the other authors declare no competing interests.
